This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by De Cree, J. Articles by Verhaegen, H. Search for Related Content PubMed PubMed Citation Articles by De Cree, J. Articles by Verhaegen, H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Blood Pressure Medicines High Blood Pressure Social Bookmarking                         What's this?

The Antihypertensive Effects of a Pure and Selective Serotonin-Receptor Blocking Agent (R 41 468) in Elderly Patients

Clinical Research Unit St. Bartholomeus, Jan Palfijn Ziekenhuis, B-2060 Merksem, Belgium

J. Leempoels

Clinical Research Unit St. Bartholomeus, Jan Palfijn Ziekenhuis, B-2060 Merksem, Belgium

W. De Cock

Clinical Research Unit St. Bartholomeus, Jan Palfijn Ziekenhuis, B-2060 Merksem, Belgium

H. Geukens

Clinical Research Unit St. Bartholomeus, Jan Palfijn Ziekenhuis, B-2060 Merksem, Belgium

H. Verhaegen

Clinical Research Unit St. Bartholomeus, Jan Palfijn Ziekenhuis, B-2060 Merksem, Belgium

In a first experiment, an acute intravenous administration of 10 mg R 41 468, a pure serotonin-receptor blocking agent with high selectivity for blood vessels and thrombocytes and devoid of central effects, dramatically reduced systolic and diastolic blood pressure in 23 elderly hypertensive patients. Heart rate and cardiac output remained virtually unchanged.

In a second double-blind placebo-controlled cross-over study a highly significant decrease of systolic and diastolic blood pressure was obtained in 14 elderly hypertensive patients during an 8-day oral treatment with 40 mg t.i.d. of R 41 468. No serious side-effects were observed. An oral maintenance therapy with R 41 468 for 3 weeks showed a further reduction of blood pressure, resulting in a normalization of blood pressure, taking into account the advanced age of the patients.

R 41 468 most probably acts by decreasing the venous capacitance bed constriction. Essential hypertension might be causally related to an impair ment of venous function, in which serotonin might be an important pressor factor.

Angiology, Vol. 32, No. 2, 137-144 (1981)
DOI: 10.1177/000331978103200206


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. Wellens, G. Peeters, B. Baeten, G. Sieben, and J. Symoens Double-Blind Comparison of Ketanserin with Placebo in Patients with Essential Hypertension Angiology, November 1, 1986; 37(11): 810 - 817. [Abstract] [PDF]